Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Pathologic and technical considerations in the treatment of ductal carcinoma in situ of the breast with lumpectomy and radiation therapyF A Vicini, N S Goldstein, L L Kestin
Cancer|May 23, 2000
The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinomaF A Vicini, L L Kestin, A A Martinez
Cancer|September 11, 2001
Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breastN S Goldstein, L L Kestin, F A Vicini
International Journal of Radiation Oncology, Biology, Physics|October 19, 1999
The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancerF A Vicini, L L Kestin, A A Martinez
Techniques in Urology|May 8, 2000
Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalationF A Vicini, L L Kestin, A A Martinez
Cancer|June 22, 2000
Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient ageN S Goldstein, F A Vicini, L L Kestin, et al.
Oncology (Williston Park, N.Y.)|May 11, 1999
Brachytherapy boost techniques for locally advanced prostate cancerF A Vicini, L L Kestin, J S Stromberg, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2001
Defining a dose-response relationship with radiotherapy for prostate cancer: is more really better?F A Vicini, A Abner, K L Baglan, et al.
Cancer|October 20, 1999
Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapyL L Kestin, F A Vicini, E L Ziaja, et al.
Journal of Surgical Oncology|April 26, 2001
Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapyF A Vicini, L L Kestin, N S Goldstein, et al.
Pageof 3